Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PSMA Imaging of Localized Prostate Cancer

Next Previous
Trial Profile

PSMA Imaging of Localized Prostate Cancer

Status: Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Jun 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs IAB 2M (Primary) ; Gallium 68 PSMA
  • Indications Prostate cancer
  • Focus Diagnostic use

    • Most Recent Events

    • 29 Jun 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Sep 2019.
    • 29 May 2019 Planned End Date changed from 1 Dec 2018 to 31 Dec 2019.
    • 29 May 2019 Status changed from completed to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top